Jim Simons Silence Therapeutics PLC Transaction History

Renaissance Technologies LLC

  • $63.1 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 09, 2024
SELL
$18.31 - $23.91 $1.19 Million - $1.55 Million
-64,800 Reduced 62.37%
39,100 $742,000
Q1 2024

May 13, 2024
BUY
$17.39 - $26.25 $1.34 Million - $2.02 Million
76,798 Added 283.37%
103,900 $2.24 Million
Q4 2023

Feb 13, 2024
BUY
$6.7 - $17.67 $181,583 - $478,892
27,102 New
27,102 $471,000

Others Institutions Holding SLN

# of Institutions
73
Shares Held
28.1M
Call Options Held
300
Put Options Held
2K
View Full List

About Silence Therapeutics plc

SLN Quotes by TradingView
  • Ticker SLN
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 35,888,400
  • Market Cap $194M
  • Description
  • Silence Therapeutics plc, a biotechnology company, focuses on the discovery and development of novel ribonucleic acid (RNA) therapeutics in hematology, cardiovascular, and other rare and metabolic indications. The company's platform includes mRNAi GalNAc Oligonucleotide Discovery platform designed to accurately target specific disease-associated...
More about SLN
Track Jim Simons's Portfolio

Track Jim Simons Portfolio

Follow Jim Simons (Renaissance Technologies LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

News

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email